A method of separating a selected ionic component from a sample, comprises contacting the sample with an ionic adsorbent whose charge density is such that the component is bound selectively in the absence of added ionic component that competitively binds the adsorbent.

Patent
   8222379
Priority
Sep 09 2002
Filed
Sep 05 2003
Issued
Jul 17 2012
Expiry
Sep 05 2023
Assg.orig
Entity
Large
0
13
EXPIRED
5. A method of separating protein A from immunoglobulin g in a buffered protein sample solution having a ph 4:0-5.5 using a selective cation-exchange adsorbent having sulphopropyl groups, consisting essentially of the following steps:
(a) contacting the buffered protein sample solution having a ph 4.0-5.5 and a conductivity 2-6 mSi/cm, protein A and immunoglobulin g with a selective cation-exchange adsorbent having sulphopropyl groups attached thereto and an ionic charge density from 10 to 100 μmol/ml to ionically bind to the immunoglobulin g, and
(b) washing the selective cation-exchange adsorbent with a buffered solution to remove unbound protein A.
1. A method of separating immunoglobulin g, an ionic protein compound of interest, from a protein sample comprising protein A using a selective cation-exchange adsorbent having a sufficiently low ionic charge density to ionically bind to immunoglobulin g consisting essentially of the following steps;
(a) contacting a protein sample having a conductivity between 2-6 mSi/cm and containing immunoglobulin g and protein A, with a selective cation-exchange adsorbent consisting of agarose beads having sulphopropyl groups attached thereto and having an ionic charge density from 10 to 100 μmol/ml;
(b) ionically binding the immunoglobulin g to the agarose beads having sulphopropyl groups attached thereto,
(c) washing the agarose beads having sulphopropyl groups attached thereto with a buffered solution to remove unbound protein A,
(d) applying a salt gradient of increasing conductivity to the agarose beads having sulphopropyl groups attached thereto, and
(e) eluting the ionically bound immunoglobulin g from the agarose beads having sulphopropyl groups attached thereto.
2. The method according to claim 1, wherein the selective cation-exchange adsorbent has an ionic charge density from 20 to 90 μmol/ml.
3. The method according to claim 1, wherein the selective cation-exchange adsorbent has an ionic charge density from 30 to 80 μmol/ml.
4. The method according to claim 1, wherein the ph of protein sample solution is 4.0-5.5.
6. The method according to claim 5, which further comprises
(c) applying a salt gradient of increasing conductivity to the selective cation-exchange adsorbent, and eluting the bound immunoglobulin g from the selective cation-exchange adsorbent.
7. The method according to claim 5, wherein the selective cation-exchange adsorbent has an ionic charge density from 20 to 90 μmol/ml.
8. The method according to claim 5, wherein the selective cation-exchange adsorbent has an ionic charge density from 30 to 80 μmol/ml.
9. The method according to claim 5, wherein the selective cation-exchange adsorbent comprises agarose beads.

This application is the U.S. National Stage Application of International Application No.: PCT/GB2003/003953, filed on Sep. 5, 2003, which claims priority to GB Application No.: 0220894.0, filed on Sep. 9, 2002.

The present invention relates to a method of separation by adsorption.

Under certain conditions, adsorbent materials containing ionic groups can bind molecules of a net opposing charge. Such processes, for example chromatography, are currently utilised in the purification and separation of biomolecules in a complex mixture such as blood or fermentation or cell culture broths.

In column chromatography, the mixture to be analysed is applied to the top of a column comprising an adsorbent material which acts as the “stationary phase”. A liquid solvent (the “mobile phase”) is passed through the column under gravity or pressure carrying the dissolved mixture. Because the different compounds in the mixture have different ionic interactions with the mobile and stationary phases, they will be carried along in the mobile phase to varying degrees, resulting in separation. A salt gradient is then usually applied to remove, in turn, separate bound components.

In such processes, the exact conditions for separation are typically determined by trial and error. The operational selectivity of an adsorbent relates to the number of molecules that bind to it as the mixture passes over; under normal conditions there is generally low specificity. Variation in the pH or ionic strength causes the interaction between individual components of the mixture and adsorbent to change. The ionic strength may be varied to allow a desired component to adsorb, but so that solvent molecules or additional components compete for available binding sites on the adsorbent, thus preventing the binding of an undesired component. Selectivity also varies depending on the physical structure of the adsorbent, for example the size distribution of pores or the chemical nature of the underivatised adsorbent.

The “working capacity” (dynamic capacity) of an adsorbent refers to the amount of a particular component which will bind to and be retained on the adsorbent. Working capacity is dependent on, inter alia, the charge density, ligand type and pore size distribution of the adsorbent.

Chang et al [Journal of Chromatography A, 827 (1998), 281-293] suggests that the protein adsorption capacity of an adsorbent is strongly correlated with the accessible surface area, and less so with the intrinsic adsorption affinity. The authors propose that uptake dynamics are influenced to a large extent by mean pore size, although it is acknowledged that other structural parameters, such as pore connectivity and adsorption affinity, may also play a role.

DePhillips et al [Journal of Chromatography A, 933 (2001), 57-72] reports that, above a threshold amount, increased charge density and ionic capacity do not necessarily result in increased protein retention. DePhillips et al postulate that a high charge density is relatively unimportant, proposing that an equivalent capacity may be attained by optimally orientating and positioning ligands of lower charge density. The data presented are based on experiments using additional salt to optimise the ionic strength.

In summary, research in this field has, over time, suggested that an increase in the charge density of the adsorbent leads, up to a point, to an, increased capacity, when added competing salts are used.

Analytical and production-scale chromatography differ, inter alia, in the way in which their performance is measured. For analytical separations, the overriding requirement is that analysis is rapid; this is often achieved using small, non-porous stationary phase particles. For large-scale chromatographic processes, capacity, recovery and throughput are typically the factors on which performance is judged. Optimum performance may be achieved by trading off throughput against selectivity and recovery. Currently, desirable working capacity is attained by using adsorbents of high charge density, with additional salt or buffer incorporated in the mobile phase. As mentioned above, the presence of additional salt (e.g. NaCl) reduces the strength of interaction between the stationary and mobile phase, allowing the specific binding of a particular component.

Current methodologies suffer from a number of limitations, one of which is cost. A major factor in the manufacture of biomolecules is the cost of raw materials. Buffered solutions are required to stabilise biomolecules against variations in pH and to reduce the likelihood of insolubilisation (precipitation). For this reason, concentrations of buffer/salt components are kept to a minimum in feed solutions and usually range from 10 to 100 mM, depending on the biomolecule to be stabilised.

The present invention is based on the realisation that, rather than using the combination of a high charge density adsorbent and added salt in the sample, desirable working capacity may be attained by varying the charge density of binding surfaces of the adsorbent. For example, while DePhillips et al reports that increased charge density and ionic capacity do not necessarily result in increased protein retention, this publication does not, on the basis of the data presented, systematically address charge density as a retention variable.

According to the invention, a method of separating a selected ionic component from a sample, comprises contacting the sample with an ionic adsorbent whose charge density is such that the component is bound selectively, in the absence of an added ionic component that competitively binds the adsorbent. The charge density of the adsorbent is preferably 10 to 100 μmol/ml, more preferably 20 to 90 μmol/ml, and most preferably 30 to 80 μmol/ml. In a preferred embodiment, the adsorbent material is cationic, the material preferably comprising sulphopropyl groups supported on a suitable substrate, for example agarose or Sepharose.

The invention utilises the finding that the charge density may be low enough to allow binding with only one ionic component, the interaction with other components being too weak for them to bind. In this way, high selectivity and capacity may be achieved at relatively low cost, since the use of large quantities of additional salts is no longer necessary.

By optimising the charge density of the adsorbent surface, the invention provides a highly selective method of separation. A method of the invention involves a marked reduction in the amount of adsorbent-bound competing molecules, allowing greater working capacities to be attained within typical ranges of pH and ionic strength.

The invention bypasses the need for the inclusion of competing ionic. components (e.g. salts) in the sample. Selectivity is achieved by using an adsorbent of predetermined charge density suitable for selective binding of the ionic component of interest over a range of ionic strengths. Thus a sample may be brought directly into contact with the adsorbent, without any pretreatment.

The present invention may be used for the separation of ionic polymeric compounds. In particular, the present invention may be used for the separation of biomolecules such as those found in complex mixtures such as blood and cell culture broths. A method of the invention may be used in the production of a monoclonal or polyclonal antibody, since antibody production generally requires a protein-specific purification step, such as protein A purification.

The adsorbent used in a method of this invention is an optionally derivatised solid phase or insoluble compound which is capable of ionic interaction with the liquid phase. The adsorbent may comprise a ceramic, synthetic or natural polymeric material, or a mixture thereof. For example, the adsorbent may comprise dextran or another natural polymer chemically or physically attached to a solid phase.

Selection of an adsorbent of appropriate charge density can be achieved using any suitable method or technique known in the art. The exact value will depend on factors known to those of ordinary skill in the art. One factor is the nature of the material to be bound and/or that which should not be bound. Another is the nature of the charged entities on the adsorbent, of which a variety can be used.

Selectivity may be achieved by using an adsorbent of sufficiently low ionic charge density such that only the component of interest binds to it. An example of this is the separation of a mixture of immunoglobulin (IgG) and protein A. Sulphopropyl groups having an (cat)ionic strength of >140 μmol/ml bind both proteins and the IgG-protein A complex. Sulphopropyl groups having weaker charge density, of approximately 75 μmol/ml, are selective towards IgG, the result being that, after elution, protein A is observed in the unbound fraction and IgG in the bound fraction.

Separation may be carried out using any suitable apparatus known in the art, for example an ion-exchange column. Elution may also be conducted by known procedures.

Techniques such as polyacrylamide gel electrophoresis (PAGE), in particular sodium dodecyl sulphate (SDS-PAGE), may be used to analyse the various fractions of separation.

The following Examples illustrate the invention, with reference to the accompanying drawings, in which:

FIG. 1 is a graph showing the elution profiles of three adsorbents of different charge density used in the separation of IgG and protein A.

FIG. 2 is similar to FIG. 1, except that the elution profiles pertain to the separation of acidic cheese whey proteins.

Separation of Immunoglobulin and Protein A

Agarose beads were manufactured, cross-linked and chemically derivatised with sulphopropyl (SP) groups of varying charge densities. For comparison, a commercially available SP adsorbent, SP Sepharose, was also used.

Immunoglobulin G and protein A were mixed in the ratio 10:1 (w/w) in a buffered solution, pH 4.0-5.5 and conductivity 2-6 mSi/cm. Three different SP-based cation-exchange adsorbents were analysed for selectivity of binding. These contained 75 μmol/ml SP agarose cationic groups, 140 μmol/ml SP agarose cationic group and SP sepharose containing 200-250 μmol/ml cationic groups.

One column volume of the protein mixture was applied to a packed column of buffer-equilibrated SP adsorbent at a flow rate of 100 to 300 cm/hr. The column was then washed with buffered solution to remove non-bound protein, and a salt gradient of increasing conductivity was applied to the column in order to elute ionically-bound proteins.

The eluent from the column was analysed for absorbance at 220 nm using an on-line detector. A variety of pH and conductivity values was utilised within the ranges defined above. Non-bound fractions and bound-eluted fractions were retained from each column run, and analysed for protein content using SDS-PAGE.

The results are shown in FIG. 1. The SP adsorbents with >140 μmol/ml cationic groups bound all the protein components; IgG, protein A and the complex between IgG and protein. However, the adsorbent with only 75 μmol/ml (dashed line) shows a substantial quantity of protein in the unbound fraction; this non-binding protein fraction was shown to be approximately 90% protein A and 10% IgG. The eluting protein fraction was shown to contain 98% IgG and 2% protein A. It is evident that the cationic adsorbent with lower charge density has not bound protein A.

Separation of Acidic Cheese Whey Proteins

Cheese whey was obtained from de-fatted milk and the pH adjusted to 4.3 with dilute phosphoric acid. One column volume of the protein mixture was applied to the three SP cationic adsorbents described in Example 1, in order to separate the different proteins. The proteins were washed from the column with a buffer solution of pH 4.3. The proteins were eluted from each adsorbent column using a gradient of increasing sodium chloride concentration (0 to 1M). The salt gradient was applied along each adsorbent column at an elution volume range of 12 to 50 ml. The eluent from each column was analysed for absorbance at 280 nm using an on-line detector.

FIG. 2 shows three elution profiles (optical density at 280 nm versus elution volume) conducted using the three different cation adsorbents under the same binding and elution gradient conditions. The three cationic adsorbents had different ionic charge densities. The optical density traces show how the acidic whey proteins were bound and eluted from each adsorbent.

The absorbance profiles show two proteins separated into distinct peaks for the adsorbents having >100 μmol/ml ionic charge density. The adsorbent with <100 μmol/ml ionic charge density was more selective, binding and eluting only one protein.

Noel, Robert John

Patent Priority Assignee Title
Patent Priority Assignee Title
4883598, Aug 14 1987 UNIVERSITEIT TWENTE AND STICHTING CENTRAAL LABORATORIUM VAN DE BLOEDTRANSFUSIEDIENST VAN HET NEDERLANDSE RODE KRUIS CLB Process for isolating coagulation factors, and adsorbent material suitable therefor
5147536, Jun 27 1989 Pharmacia LKB Biotechnology AB Anion exchanger with a ligand comprising two quaternary amino groups at a distance of two atoms
5174536, May 08 1989 Dometic Corporation Awning hook for recreational vehicle
5429746, Feb 22 1994 GlaxoSmithKline LLC Antibody purification
5644036, Oct 17 1990 Burroughs Wellcome Company Purified immunoglobulin
5945520, Sep 23 1994 Massey University Chromatographic resins and methods for using same
5986063, Jul 31 1998 Wisconsin Alumni Research Foundation Isolating β-lactoglobulin and α-lactalbumin by eluting from a cation exchanger without sodium chloride
6498236, Aug 30 1996 Upfront Chromatography A/S Isolation of immunoglobulins
7214321, Jul 17 2000 CYTIVA BIOPROCESS R&D AB Adsorption method and ligands
20050020812,
20060194953,
WO9726797,
WO9808603,
//////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Sep 05 2003EMD Millipore Corporation(assignment on the face of the patent)
Jan 07 2005NOEL, ROBERT JOHNMillipore CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0168170927 pdf
Mar 07 2007BIOPROCESSING LIMITEDMILLIPORE UK LIMITEDCORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE, RECEIVING PARTY PREVIOUSLY RECORDED ON REEL 019147 FRAME 0563 ASSIGNOR S HEREBY CONFIRMS THE ASSIGNMENT OF THE RIGHTS, TITLE AND INTEREST IN THE FOLLOWING PATENTS FROM BIOPROCESSING LIMITED TO MILLIPORE UK LIMITED 0310610401 pdf
Mar 07 2007BIOPROCESSING LIMITEDMillipore CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0191470563 pdf
Jan 01 2012EMD Millipore CorporationMillipore CorporationCORRECTIVE ASSIGNMENT TO CORRECT THE OWNER NAME FOR PATENT APPLICATIONS 10863379 AND 10521730 PREVIOUSLY RECORDED ON REEL 027620 FRAME 0891 ASSIGNOR S HEREBY CONFIRMS THE OWNER NAME SHOULD REVERT BACK TO MILLIPORE CORPORATION 0314300178 pdf
Jan 01 2012Millipore CorporationEMD Millipore CorporationCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0276200891 pdf
Date Maintenance Fee Events
Feb 26 2016REM: Maintenance Fee Reminder Mailed.
Jul 17 2016EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jul 17 20154 years fee payment window open
Jan 17 20166 months grace period start (w surcharge)
Jul 17 2016patent expiry (for year 4)
Jul 17 20182 years to revive unintentionally abandoned end. (for year 4)
Jul 17 20198 years fee payment window open
Jan 17 20206 months grace period start (w surcharge)
Jul 17 2020patent expiry (for year 8)
Jul 17 20222 years to revive unintentionally abandoned end. (for year 8)
Jul 17 202312 years fee payment window open
Jan 17 20246 months grace period start (w surcharge)
Jul 17 2024patent expiry (for year 12)
Jul 17 20262 years to revive unintentionally abandoned end. (for year 12)